Cwm, LLC Halozyme Therapeutics, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,530 shares of HALO stock, worth $78,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,530

Previous 862 77.49%

Holding current value

$78,320

Previous $45,000 95.56%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$51.3 - $64.42 $34,268 - $43,032	668 Added 77.49%	1,530 $88,000
Q2 2024 Jul 09, 2024	BUY	$37.81 - $52.4 $2,344 - $3,248	62 Added 7.75%	862 $45,000
Q1 2024 Apr 05, 2024	SELL	$33.68 - $41.95 $10,541 - $13,130	-313 Reduced 28.12%	800 $33,000
Q4 2023 Feb 01, 2024	SELL	$33.32 - $42.1 $28,455 - $35,953	-854 Reduced 43.42%	1,113 $41,000
Q3 2023 Oct 11, 2023	BUY	$36.46 - $44.03 $31,246 - $37,733	857 Added 77.21%	1,967 $75,000
Q2 2023 Aug 03, 2023	BUY	$30.28 - $38.74 $7,933 - $10,149	262 Added 30.9%	1,110 $40,000
Q1 2023 Apr 28, 2023	BUY	$32.86 - $55.7 $15,378 - $26,067	468 Added 123.16%	848 $32,000
Q4 2022 Feb 01, 2023	BUY	$40.06 - $59.44 $5,688 - $8,440	142 Added 59.66%	380 $22,000
Q3 2022 Oct 27, 2022	BUY	$38.53 - $51.78 $7,628 - $10,252	198 Added 495.0%	238 $9,000
Q2 2022 Jul 28, 2022	BUY	$37.35 - $48.3 $896 - $1,159	24 Added 150.0%	40 $2,000
Q1 2022 Apr 21, 2022	SELL	$31.97 - $41.06 $2,110 - $2,709	-66 Reduced 80.49%	16 $1,000
Q4 2021 Jan 31, 2022	BUY	$31.82 - $40.75 $1,750 - $2,241	55 Added 203.7%	82 $3,000
Q1 2021 Sep 15, 2021	BUY	$39.51 - $51.45 $1,066 - $1,389	27 New	27 $1,000
Q1 2021 Apr 27, 2021	SELL	$39.51 - $51.45 $1,066 - $1,389	-27 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$25.81 - $43.62 $696 - $1,177	27 New	27 $1,000
Q4 2020 Jan 27, 2021	SELL	$25.81 - $43.62 $696 - $1,177	-27 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$25.74 - $29.63 $694 - $800	27 New	27 $1,000
Q3 2020 Oct 19, 2020	SELL	$25.74 - $29.63 $694 - $800	-27 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$16.25 - $26.81 $438 - $723	27 New	27 $1,000
Q2 2020 Jul 22, 2020	SELL	$16.25 - $26.81 $438 - $723	-27 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$13.9 - $21.83 $375 - $589	27 New	27 $1,000
Q1 2020 Apr 28, 2020	SELL	$13.9 - $21.83 $375 - $589	-27 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$14.93 - $19.53 $403 - $527	27 New	27 $1,000
Q4 2019 Jan 27, 2020	SELL	$14.93 - $19.53 $403 - $527	-27 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$15.2 - $17.69 $410 - $477	27 New	27 $1,000
Q3 2019 Oct 22, 2019	SELL	$15.2 - $17.69 $410 - $477	-27 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$14.75 - $17.26 $398 - $466	27 New	27 $1,000
Q2 2019 Jul 31, 2019	SELL	$14.75 - $17.26 $398 - $466	-27 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$13.94 - $17.58 $376 - $474	27 New	27 $0

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.13B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account